1. Use of a Urine Anastrozole Assay to Determine Treatment Discontinuation Among Women With Hormone-Sensitive Breast Cancer: A Pilot Study Hillyer, Grace A.; Hershman, Dawn L.; Danaceau, Jonathan; Rotsides, Demetra Z.; Maurer, Matthew A.; Kalinsky, Kevin; Crew, Katherine D.; Neugut, Alfred I. 2012 Articles MedicineOncology
2. Targeting filamin A reduces K-RAS–induced lung adenocarcinomas and endothelial response to tumor growth in mice Nallapalli, Rajesh; Ibrahim, Mohamed; Zhou, Alex; Bandaru, Sashidar; Sunkara, Sai Naresh; Redfors, Björn; Pazooki, David; Zhang, Yin; Borén, Jan; Cao, Yihai; Bergo, Martin; Akyürek, Levent 2012 Articles OncologyMedicine
3. Prediction of response to therapy with ezatiostat in lower risk myelodysplastic syndrome Galili, Naomi; Tamayo, Pablo; Botvinnik, Olga; Mesirov, Jill; Brooks, Margarita; Brown, Gail; Raza, Azra 2012 Articles MedicineOncology
4. Phase 1 dose-ranging study of ezatiostat hydrochloride in combination with lenalidomide in patients with non-deletion (5q) low to intermediate-1 risk myelodysplastic syndrome (MDS) Raza, Azra; Galili, Naomi; Mulford, Deborah; Smith, Scott; Brown, Gail; Steensma, David; Lyons, Roger; Boccia, Ralph; Sekeres, Mikkael; Garcia-Manero, Guillermo; Mesa, Ruben 2012 Articles MedicineOncology
5. Novel therapeutic agents for cutaneous T-Cell lymphoma Jain, Salvia; Zain, Jasmine; O’Connor, Owen Anthony 2012 Articles MedicineOncology
6. Gastroenterologists' Perceived Barriers to Optimal Pre-Colonoscopy Bowel Preparation: Results of a National Survey Hillyer, Grace A.; Basch, Corey H.; Basch, Charles E.; Lebwohl, Benjamin; Kastrinos, Fay; Insel, Beverly J.; Neugut, Alfred I. 2012 Articles OncologyEpidemiologyMedicine